United Therapeutics Corp (UTHR)
363.13
-23.14
(-5.99%)
USD |
NASDAQ |
Nov 15, 16:00
363.13
0.00 (0.00%)
After-Hours: 20:00
United Therapeutics Free Cash Flow (Quarterly): 300.70M for Sept. 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 300.70M |
| June 30, 2024 | 187.10M |
| March 31, 2024 | 338.30M |
| December 31, 2023 | 72.00M |
| September 30, 2023 | 280.50M |
| June 30, 2023 | 61.60M |
| March 31, 2023 | 333.50M |
| December 31, 2022 | 88.70M |
| September 30, 2022 | 189.80M |
| June 30, 2022 | 110.00M |
| March 31, 2022 | 275.20M |
| December 31, 2021 | 104.00M |
| September 30, 2021 | 162.30M |
| June 30, 2021 | 131.90M |
| March 31, 2021 | 79.20M |
| December 31, 2020 | 113.90M |
| September 30, 2020 | 235.10M |
| June 30, 2020 | 145.80M |
| March 31, 2020 | 201.60M |
| December 31, 2019 | 77.80M |
| September 30, 2019 | 171.80M |
| June 30, 2019 | 112.60M |
| March 31, 2019 | -652.50M |
| December 31, 2018 | 33.60M |
| September 30, 2018 | 196.00M |
| Date | Value |
|---|---|
| June 30, 2018 | 126.30M |
| March 31, 2018 | 238.10M |
| December 31, 2017 | -113.60M |
| September 30, 2017 | 236.50M |
| June 30, 2017 | 49.80M |
| March 31, 2017 | 215.20M |
| December 31, 2016 | 153.90M |
| September 30, 2016 | 219.60M |
| June 30, 2016 | 115.30M |
| March 31, 2016 | 116.80M |
| December 31, 2015 | -6.00M |
| September 30, 2015 | 196.70M |
| June 30, 2015 | 37.20M |
| March 31, 2015 | 105.10M |
| December 31, 2014 | 88.40M |
| September 30, 2014 | 194.89M |
| June 30, 2014 | -67.32M |
| March 31, 2014 | 91.92M |
| December 31, 2013 | 91.01M |
| September 30, 2013 | 129.88M |
| June 30, 2013 | 79.01M |
| March 31, 2013 | 93.46M |
| December 31, 2012 | 83.95M |
| September 30, 2012 | 86.72M |
| June 30, 2012 | 43.75M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
61.60M
Minimum
Jun 2023
338.30M
Maximum
Mar 2024
174.45M
Average
154.05M
Median
Free Cash Flow (Quarterly) Benchmarks
| Liquidia Corp | -23.95M |
| Pfizer Inc | 6.063B |
| Tonix Pharmaceuticals Holding Corp | -9.919M |
| Ardelyx Inc | 0.364M |
| Cingulate Inc | -3.743M |